Electromed, Inc. manufactures, markets and sells products that provide airway
clearance therapy, including the SmartVest R Airway Clearance System
(“SmartVest System”) and related products, to patients with compromised
pulmonary function. The SmartVest System generates High Frequency Chest Wall
Oscillation (“HFCWO”), a technique for airway clearance therapy, also known as
High Frequency Chest Compression. The SmartVest System has been approved by the
FDA to treat the condition of excess lung secretions. Consequently, it may be
prescribed to patients suffering from cystic fibrosis, chronic obstructive
pulmonary disease, muscular dystrophy, post-surgical airway complications and
a variety of other diseases and conditions associated with impaired lung and
airway capacity. By clearing airways, patients are able to rid their lungs of
retained secretions and are therefore less likely to develop lung infections
such as pneumonia. The SmartVest System is a doctor-prescribed therapy and,
depending on the circumstances of the patient, its cost to an individual is
generally reimbursable by Medicare, Medicaid and private insurance, or a
combination of the three.
Electromed, Inc. was incorporated in Minnesota in 1992. Our corporate
headquarters are located at 500 Sixth Avenue NW, New Prague, Minnesota 56071.
Our telephone number is (952) 758-9299. Our websites can be found
at www.electromed.com and www.smartvest.com.